Fort LP’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Fort LP’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,235	Closed	-$242K	–	308
2020 Q3	$242K	Buy	+3,235	New	+$216K	0.1%	278
2020 Q2	–	Sell	-2,515	Closed	-$106K	–	348
2020 Q1	$106K	Buy	+2,515	New	+$115K	0.02%	316

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fort LP's ARNA Position: Q4 2020 in Review

Fort LP sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 3,235 shares — an estimated $242K sold.

Fort LP first reported a position in ARNA in Q1 2020 and held it in 2 quarters. The position peaked at $242K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

Fort LP reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
Fort LP sold 3,235 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $242K.
Fort LP first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 2 quarters.
Fort LP's Arena Pharmaceuticals Inc position peaked at $242K in Q3 2020.
254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Fort LP's 13F filing for Q4 2020, filed 12 Feb 2021.